BCM
ALAB icon

Bayesian Capital Management’s Astera Labs ALAB Stock Holding History

Bayesian Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,998
Closed -$438K – 321
2026
Q1 		$438K Buy
+3,998
New +$569K 0.53% 62
2025
Q3 		– Sell
-6,312
Closed -$571K – 845
2025
Q2 		$571K Buy
+6,312
New +$499K 0.09% 258
2025
Q1 		– Sell
-5,100
Closed -$675K – 1021
2024
Q4 		$675K Buy
+5,100
New +$479K 0.08% 310

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bayesian Capital Management's ALAB Position: Q2 2026 in Review

Bayesian Capital Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 3,998 shares — an estimated $438K sold.

Bayesian Capital Management first reported a position in ALAB in Q4 2024 and held it in 3 quarters. The position peaked at $675K in Q4 2024. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Bayesian Capital Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 3,998 Astera Labs shares in Q2 2026, an estimated $438K.
  • Bayesian Capital Management first reported a position in Astera Labs in Q4 2024 and held it in 3 quarters.
  • Bayesian Capital Management's Astera Labs position peaked at $675K in Q4 2024.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.